quality of care. Subsequent reductions in morbidity and mortality and improvements in quality of life are expected. Managed care is included as an effect modifier implemented before, concurrent with, or after MHBL, and expected to offset anticipated increases in cost and utilization from MHBL.
Research Questions
This review addressed a comprehensive research question: Is legislation for MH/SA benefits effective in improving MH in the community by increasing (1) access to care, (2) financial protection, (3) appropriate utilization of MH services, (4) diagnosis of mental illness, and (5) quality of care; by reducing (6) morbidity and (7) mortality; and by improving (8) quality of life?
Outcome Measures Used to Determine Effectiveness
Outcomes assessed in this review are defined briefly here. See Appendix B (available online) for full definitions and examples.
Inclusion criteria-Studies were included if they: (1) evaluated an intervention relating to MHBL, including executive orders at the federal or state level; (2) measured and reported at least one review outcome; and (3) were reported in English.
Exclusion criteria-Studies were excluded if they were: (1) based primarily on simulation data; (2) reforms to restructure care only, such as Medicaid waivers; (3) singledisease mandates, such as coverage mandate for autism only; and (4) implemented outside the U.S., because of differences in health systems and legislation.
Abstraction and Evaluation of Studies
Two reviewers evaluated each study using an adaptation of a standardized abstraction form, which included a quality assessment (www.thecommunityguide.org/methods/ abstractionform.pdf). 29 Disagreements were resolved by discussion and team consensus. DistillerSR, version 1 was used to manage references, screen citations, and abstract data. Microsoft Excel, 2010 was used for effect size calculation and other analyses. Papers based on the same study data set were linked; only the paper with the most complete data (e.g., longest follow-up) was included in analyses. See Appendix C (available online) for more details.
Summarizing the Body of Evidence on Effectiveness
Effect measurement and data synthesis-Effect estimates of absolute percentage point (pct pt) change or relative percentage change were calculated with corresponding 95% CIs and adjusted for baseline data when possible. Regression coefficients or ORs were used as the effect estimates when reported.
Summary effect estimates (medians), interquartile intervals (IQIs), and number of studies are reported when outcomes contained five or more data points. Results for most outcomes of interest were synthesized descriptively and p-values are reported when available. Tables illustrating the effect direction are used to display effects based on methods developed by Thomson and Thomas 34 (see Appendix C, available online, for formulas and details on data synthesis). Analyses were conducted in 2012.
Evidence Synthesis Study Characteristics
A total of 15,341 papers were identified from the literature search and screened by title and abstract ( Figure 2 ). Further detailed review of full-text papers produced 30 quasiexperimental and observational studies from 37 papers that met inclusion criteria. Of these, 11 studies (reported in 16 papers 12, 24, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] ) were of greatest design suitability, nine (reported in ten papers 20, [35] [36] [37] [52] [53] [54] [55] 56, 57 ) were of moderate suitability, and ten (reported in 11 papers [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] ) were least suitable. Twelve studies (reported in 18 papers 20, 24, 37, 41 ,43-47, [49] [50] [51] [52] [55] [56] [57] 61, 62 ) were of good quality of execution and 18 (reported in 19 papers 12, 35, 36, [38] [39] [40] 42, 48, 53, 54, [57] [58] [59] [60] [63] [64] [65] [66] [67] [68] ) were fair. Twenty-eight studies (reported in 35 papers 12, 20, 24, [57] [58] [59] [60] [61] [62] [63] [65] [66] [67] [68] ) examined effects of state or federal MH/SA parity policies or legislation, and two 56, 64 examined effects of state-mandated coverage for MH and SA. Six studies 35, [37] [38] [39] [40] 42 examined effects of comprehensive parity legislation or policies. No studies evaluated the 2010 ACA. Most studies used a nationwide sample to examine effects of federal legislation or state mandates, and were conducted between 1990 and 2011.. Summary evidence tables that present further details of each study are provided at www.thecommunityguide.org/mentalhealth/SET-benefitslegis.pdf. No prior systematic reviews on the effectiveness of MHBL were found in the literature.
Overall Results
Access to care-Seven studies in eight papers 39, 53, 60, [63] [64] [65] [66] 68 reported changes in access to care, and three studies in four papers 60, 63, 64, 68 (eight data points) reported percentage change of employees with coverage for MH/SA services. Median absolute pct pt increase for employees covered by MH/SA services was 13.6 (IQI= −3.8, 48.0). Four studies 39, 53, 65, 66 provided additional evidence. One of those 65 reported that restrictions for MH/SA remained greater than restrictions for physical health services for 89% of plans after implementation of the 1996 MHPA. Another study 66 reported the percentage of employers covering MH/SA benefits before and after MHPA implementation for specific services; overall results suggested no change in proportion of employers covering MH/SA benefits. Two studies 39, 53 found that more people with an MH need (including SA) perceived their access to MH/SA care to be easier after implementation of a state parity mandate, with increases of 8.1 and 3.3 pct pts (p>0.05), respectively.
Financial protection-Five studies in six papers assessed financial protection, 36, 44, 47, 51, 52, 67 and effectiveness was shown for all financial-protection outcomes. One study 36 found the proportion of people reporting out-of-pocket spending of >$1,000 and people reporting a financial burden for children's MH care in parity states was 7.1 and 9.4 pct pts less, respectively, than for people in non-parity states. Two studies with seven study arms 52, 67 reported that MHBL was associated with a median decline of 4.6 pct pts (IQI= −12.0, −4.0) in the percentage of overall out-of-pocket healthcare spending used to pay for MH services. Two studies reported in three papers 44, 47, 51 found an overall decrease in MH out-of-pocket spending per user comparing those covered under FEHB versus those covered by self-insurance plans: one 47 reported an annual median decline of $9 in adult-only plans (from baselines of $202-$257); similarly, another 51 reported an annual median decline of $37 in child and adult plans (from baselines of $251-$418) and a subgroup analysis 44 also reported an annual median decline of $51 in child-only plans (from baselines of $724-$1,131).
Appropriate utilization-Nine studies assessed appropriate utilization as an increase in the number of: (1) visits to MH specialists 35, 39, 42, 56 ; (2) evidence-based or guidelineconcordant care visits 24, 40 ; or (3) MH visits for people with a MH need. 12, 35, 38, 39, 46 In general, studies reported positive effect estimates following MHBL (specifically, state mandates, FEHB, or Medicare parity in cost sharing). Three studies 35, 39, 42 reported greater MH specialist service use in those states with parity laws compared to those without (Table  1) . Two studies 24, 40 reported increases in adoption of guideline-concordant care as a result of MH parity implementation ( Table 2) . Effects of MH parity on increasing service utilization among populations identified as having an MH need, reported in five studies, 12, 35, 38, 39, 46 are shown in Table 3 . All five studies reported increased service utilization among populations in need.
Diagnosis of mental health conditions-One study in two papers 20, 24 reported relative increases of 13.0% in identification of major depressive disorders and 25.6% in SA disorders, and absolute increases of 0.3 pct pts (p<0.05) and 0.1 pct pts, respectively, following implementation of the FEHB parity policy. 46 assessed the effect of state parity mandates on MH-related morbidity. In five states that enacted state parity mandates during the study period, there was a 3.2-pct pt decrease in the prevalence of people reporting poor MH. Similarly, the prevalence of people reporting poor MH was 2.8 pct pts lower in states that had state mandated parity for the entire study period than for those without.
Morbidity-One study
Mortality-Two studies 37, 41 reported evidence on reduced suicide rate using national data from the same source. Klick and Markowitz 37 conducted a two-stage least squares regression, controlling for state-level variables, and reported regression coefficients of −0.145 for partial parity versus −0.212 for full parity states, indicating a reduced suicide rate. However, neither of these results was significant (p>0.05). In a similar study using updated classification of state parity status, Lang 41 found, among states that enacted parity mandates, the suicide rate per 100,000 decreased significantly by a relative 5% (p<0.01) compared with states that enacted no or weak parity mandates.
Quality of care and quality of life-In this review, no independent measures of quality of care or quality of life were reported.
Subgroup analyses-Overall, six studies 35, [37] [38] [39] [40] 42 examined the impact of strength and scope of legislation on the outcomes of utilization, appropriate utilization, and suicide rates ( Table 4 ). The first group of studies had an indirect comparison of the effectiveness of comprehensive parity versus no/weak parity to the effectiveness of all types of parity versus no/weak parity (the categories of parity are not mutually exclusive; Table 4 , top). The second set of studies (Table 4 , bottom) had an indirect comparison of comprehensive parity to more limited forms of parity (i.e., weaker parity); these categories are mutually exclusive.
Additional evidence on utilization-Sixteen studies in 18 papers 12, 20, 38, 39, 43, 44, [46] [47] [48] [49] [50] [51] [52] 54, 56, 59, 61, 62, 67 reported utilization of MH or SA services but did not provide sufficient information to meet the criteria for appropriate utilization. Results were mixed (see Appendix D, available online, for more details).
Applicability
All studies were conducted in the U.S., among people who were covered by private or public insurance. Analysis by age 36, 44 indicated that effects for financial protection were similar for children and adults. Analysis by region 43, 44, 60, 64, 68 and employer size 46, 52, 60, 65, 66 showed no difference in access to care. No studies reported outcomes by health plan type or racial/ethnic minority groups; however, the body of evidence includes national samples that should be representative of all health plan types and racial/ethnic groups.
One study 40 reported evidence on effectiveness in low-SES populations for appropriate utilization among Medicare enrollees aged ≥65 years; MH benefit changes were most effective for people in the lowest income and education groups (p<0.05). Another study 46 found that employees working for small employers (<100 employees) were more likely to use MH services after implementation of state parity mandates, regardless of income, and state parity mandates were most effective in increasing utilization of any MH service for people in the lowest income group (p<0.05). In summary, the body of evidence is applicable to the insured population across the U.S., with some evidence for specific outcomes on children, low-income and low-education groups, and employees of small employers. MHBL does not apply to the uninsured population.
Additional Benefits and Harms
One study 56 in this review suggested that increased MH service use after implementation of MHBL might have an additional benefit of decreasing utilization of social or other health services, because of the association between mental and physical health. 56, 69 These authors 56 and others 70, 71 have speculated that insurance coverage-related discrimination for MH could decrease as a result of legislation because insurance providers would no longer be able to refuse coverage for these conditions. Two potential harms of MHBL described earlier are moral hazard and adverse selection. No studies in this review provided evidence on moral hazard. However, increased adverse selection was found in one study 61 following implementation of a state parity law, but only in a subgroup that allowed beneficiaries to choose among health plans.
Some researchers have suggested that employers may drop MH/SA coverage to avoid being subject to MHBL. 72, 73 A national study conducted in 2010 73 found that although 5% of employers dropped MH/SA coverage that year, only 2% reported dropping coverage after passage of the 2008 MHPAEA. The U.S. General Accounting Office 2011 Mental Health and Substance Abuse Report 72 found similar results, showing that approximately 2% of employers discontinued coverage in 2010 of either: (1) MH and substance use; or (2) only substance use disorders. Current provisions of the 2010 ACA will require state Medicaid programs and insurance plans in state health insurance exchanges to cover both MH and SA as one of ten categories of essential health benefits in 2014. 74, 75 
Considerations for Implementation
Challenges to effective implementation of MHBL include underutilization, access to services, and exemptions. This legislation alone is not sufficient to address underutilization of MH/SA services in the U.S. 10 Additionally, it is unclear to what extent MHBL reduces public stigma, a barrier to utilization of MH/SA services. [76] [77] [78] Low awareness of legislative provisions also may hinder service utilization by beneficiaries. 79 Conversely, limited numbers of MH providers 80 and inpatient beds 81 restrict access to services, especially in rural areas. 81 In some cases, covered services and treatments are not clearly defined in the legislation, allowing individual health plans to limit benefits provided for certain conditions or illnesses. 82 Further, investigational treatments typically are not covered by insurance plans, thus limiting access to care. 82 Another implementation issue concerns exemptions that may decrease the potential reach of MHBL. Larger employers often self-insure, and are therefore exempt from MH insurancerelated state mandate laws because of the 1974 Employee Retirement Income Security Act (ERISA). 83 Both employers with <50 employees and group health plans that demonstrate an MH benefit-related cost increase of 1% (MHPA) and 2% (MHPAEA) are exempt from the respective federal legislation. 16 
Conclusions

Summary of Findings
Results of this review suggest that MHBL has favorable effects on financial protection and access to care. Evidence on increasing appropriate utilization of MH services and certain evidence on aspects of MH care (e.g., increased diagnosis of mental illness) is also favorable, with larger effects for comprehensive parity legislation. In addition, MHBL, and specifically comprehensive parity, is associated with favorable effects for health-related outcomes of reducing suicides and morbidity, although the small number of studies limits inferences.
Discussion
MHBL creates levels of financial protection and access to care that are no more restrictive for certain insured individuals seeking MH/SA services than for those seeking services for physical health conditions. 26 Nonetheless, accurately interpreting these results requires consideration of two caveats:
1. Simultaneous implementation of MHBL and adoption of managed care have made isolating the effects of MHBL difficult. Overall, the interrelationship between managed care and MHBL is unclear; managed care might reduce moral hazard and ensure appropriateness of services rendered following improved financial protection 84 or it might restrict access to services through excessive or inappropriate use of management tools. 56 Further, some parity legislation applies only to managed care insurance plans, or explicitly authorizes and encourages the use of managed care. 84 2. Of 37 included papers, 35 examined effects of state, federal, or executive-ordered MH/SA parity, whereas the remaining two papers 56,64 investigated effects of mandating coverage for MH and SA for only the outcomes of access and utilization. Therefore, effects on most outcomes can be associated with some level of parity legislation.
The 2010 ACA affects MH/SA parity in two critical ways. First, the ACA extends the reach of the two previous federal parity laws to certain types of health plans not previously required to comply. 17, 74 Second, ACA contains provisions mandating that: (1) MH and SA services in general are covered by certain health insurance issuers; and (2) specific MH and SA disorder services are covered by specified plan types (i.e., qualified health plans, certain Medicaid plans, and plans offered through the individual market). 17, 74 Combined, these two new provisions extend the requirements and reach of MH/SA parity.
Limitations
A number of challenges in studying the effects of MHBL were limitations in the current review but do not threaten validity of findings substantially. First, there was difficulty isolating the effects of managed care from those of MHBL. Second, many studies did not report sufficient information to assess appropriate utilization. Third, there is potential for data dependency (i.e., same people or populations represented more than once in the body of evidence). Some studies in this review used the same national data sources, such as the Healthcare for Communities survey 85 or MarketScan database, 86 but the extent of overlap is unclear. Fourth, data sources might introduce bias either through survey data, which are based on self-reporting and potentially subject to recall bias or claims data, which might lead to spuriously low results for MH/SA service use because of under-reported diagnoses and underutilization of treatment. 45 Fifth, classifications of strength of state parity mandates differed across studies. Although many authors relied on the National Conference of State Legislatures, 17 others used alternative sources or their own classification. Sixth, few studies of private employer plans controlled for exemptions, such as the 1974 ERISA, which exempts self-insured employers (typically large employers with >500 employees) from state mandates. 83 Additionally, no studies controlled for the small employer exemption (≤50 employees) or cost exemption (1%-2% cost increase following parity implementation) of the two federal laws. 16 Failure to control for these exemptions could lead to underestimates of MHBL effects.
Evidence Gaps
Research evaluating effects of MHBL on MH outcomes is limited. Studies are needed to assess effects of legislation on morbidity (e.g., symptom reduction remission and recovery), mortality, quality of life, and aspects of quality of care (e.g. intensity and duration of treatment, and coordination of care). Most studies that reported utilization did not assess appropriateness of use as indicated by guideline-concordant care or patient need. In addition, researchers often reported outcomes that combined inpatient and outpatient utilization, but the desired direction (i.e., increase or decrease) differed with various patient conditions.
Reporting types of utilization separately and including measures of appropriate utilization will allow for assessments of appropriate care.
Research is also needed to clarify the role of MHBL in reducing health-related disparities and improving MH outcomes among subgroups (e.g., low-SES groups, racial/ethnic minorities, and various MH conditions) that may experience greater issues with access to care and impairments. Moreover, evidence is limited for people covered by public health insurance (e.g., Medicaid and Medicare). Further, evaluations are needed to examine effects of the 2008 MHPAEA, which contains more requirements for parity than the 1996 MHPA and the 2010 ACA, which currently has provisions to establish parity for MH/SA in many insurance plans in 2014. 74 Finally, studies that include a longer follow-up (>3 years) are necessary to assess long-term effects of MHBL. indication of approval) that such plan meets the criteria for certification described in section 1311(c) issued or recognized by each Exchange through which such plan is offered; (B) provides the essential health benefits package described in section 1302(a); and (C) is offered by a health insurance issuer that-(i) is licensed and in good standing to offer health insurance coverage in each State in which such issuer offers health insurance coverage under this title (ii) agrees to offer at least one qualified health plan in the silver level and at least one plan in the gold level in each such Exchange; (iii) agrees to charge the same premium rate for each qualified health plan of the issuer without regard to whether the plan is offered through an Exchange or whether the plan is offered directly from the issuer or through an agent; and (iv) 
Appendix B: Mental Health Outcome Definitions and Examples
Access to care
The ability of those with public or private insurance to obtain MH/SA care. Examples include workforce coverage for mental health/substance abuse (MH/SA) benefits and insured's perception of that coverage.
Financial protection
The reduction in out-of-pocket costs paid by an individual for MH/SA services. 1,2 Examples include measures of decreased financial burden, dollar amount, and percentage of out-ofpocket spending.
Appropriate utilization
Receiving the proper amount and quality of services when needed, including utilization of MH/SA services by people with a MH/SA need, services rendered by MH specialists (e.g., psychiatrist, psychologist, social worker), or receipt of services conforming to evidencebased guidelines for MH/SA care.
Diagnosis
The determination that a person meets established criteria for a MH condition. Examples include recognition of newly identified mental health-related conditions, such as depression or substance abuse.
Quality of care
"The degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge." Examples include; appropriateness of treatment; type, intensity, and duration of treatment; patient satisfaction; and coordination of care. 
Mortality
Any death associated with a MH condition Examples include suicides, deaths related to eating disorders, and alcohol and drug (i.e., substance) abuse.
Quality of life
Health-related quality of life, "an individual's or group's perceived physical and mental health over time." 4 Outcome measures that report health-related quality of life include the Medical Outcomes Study Short Forms 12 5 and 36, 6 the Sickness Impact Profile, 7 and Quality of Life Index for Mental Health. 8
Appendix C: Data Abstraction and Synthesis
Abstraction and Evaluation of Studies
Two reviewers read and evaluated each study that met inclusion criteria using an adaptation of a standardized abstraction form (www.thecommunityguide.org/methods/ abstractionform.pdf) 9 that included data describing elements of mental health benefits legislation, population characteristics, study characteristics, study results, applicability, potential harms, additional benefits, and considerations for implementation. Assessment of study quality included study design and execution, which were evaluated using these criteria: studies with greatest design suitability were those with prospective data on exposed/ comparison populations; studies with moderate design suitability were those with retrospective data on exposed/comparison populations or with data collected at multiple pre and post-intervention time points; studies with least-suitable designs were cross-sectional studies with no comparison population (including one-group single pre-and postmeasurement). Studies were assigned limitations for quality of study execution based on seven categories of threats to validity identified in studies, up to a total of nine limitations across six categories: (1) description of study population and intervention to include at least year of intervention, study location and population characteristics (one limitation); (2) sampling to include representation, selection bias, and appropriate control group (one limitation); (3) measurement of exposure to include reliability of outcome and exposure variables (two limitations); (4) data analysis to include appropriate statistical tests and controls (e.g., time, intensity, secular trends, plan types, condition of patient, etc.) and adjustment for multi-year data (one limitation); (5) interpretation of results/sources of potential bias to include attrition < 80%, comparability of comparison group, recall bias for surveys, accounting for overlapping laws and adequate controls for confounding (three limitations), and (6) other issues such as missing data (one limitation). Study quality of execution was characterized as good (0-1 limitation), fair (2-4 limitations), or limited (≥5 limitations). Studies with good or fair quality of execution and any level of design suitability were included in the analyses. Papers based on the same study dataset were linked; only the paper with the most complete data (e.g., longest follow-up) for each outcome was included in each analysis.
Studies were stratified by five subgroups when data were available: strength and scope of legislation, setting, clients, employer size, and health plan type.
Effect Measurement and Formulas
Effect estimates for absolute percentage point change and relative percentage change were calculated using the following formulas:
For studies with pre-and post-measurements and concurrent comparison groups:
where:
I post = last reported outcome rate or count in the intervention group after the intervention;
I pre = reported outcome rate or count in the intervention group before the intervention; C post = last reported outcome rate or count in the comparison group after the intervention;
C pre = reported outcome rate or count in the comparison group before the intervention.
Effect estimates for studies with pre-and post-measurements but no concurrent comparison:
Outcome data were reported as proportions when possible and were converted to effect estimates of absolute percentage point change or relative percent change.
Summarizing and Synthesizing the Body of Evidence on Effectiveness
The rules of evidence under which the Community Preventive Services Task Force makes its determination address several aspects of the body of evidence, including the number of studies of different levels of design suitability and execution, consistency of the findings among studies, public health importance of the overall effect estimate, and balance of benefits and harms of the intervention. [9] [10] [11] Overall, six studies [13] [14] [15] 17, 19, 21 examined the impact of strength and scope of legislation on the outcomes of utilization, appropriate utilization, and suicide rates. The first group of studies had an indirect comparison of the effectiveness of comprehensive parity versus no/ weak parity to the effectiveness of all types of parity versus no/weak parity (these categories of parity are not mutually exclusive; Table D-4, top). Pacula and Sturm 13 found differential effects for MH service visits among those identified with an MH need when analyzing comparisons of states with a strict parity mandate and states with all levels of parity (reference group: non-parity states). There were no such differences for the general population. Barry 15 found no differential effects for more visits for MH specialty visits in full parity states comparisons than all levels of parity comparisons (reference group: no/ weak parity states). There were no differential effects for outcomes of proportion of mental health/substance abuse (MH/SA) users and specialty users. Klick and Markowitz 21 found differential effects for greater reductions in adult suicide rates in states with full parity compared to states with more loosely defined parity mandates.
The second set of studies (Table D Although not included in this review, there is also some evidence of favorable effects when employers voluntarily expanded MH/SA benefits to achieve parity. One study 37 reported that a reduction in copayments resulted in increased utilization of substance use services. Two studies 38, 39 reported the combination of de-stigmatization and lower copayments was associated with a significant increase in the probability of initiating MH treatment by 1.2% and 0.74%, respectively (p<0.01 for each). And one study 40 reported that benefit changes and de-stigmatization increased the likelihood of outpatient, pharmaceutical, or any MH treatment among intervention employers compared to control employers. Analytic framework: hypothesized ways in which mental health benefits legislation improves mental health. 40 Adults with public insurance Full parity versus intermediate parity % received follow-up in 7 days ▲ % received follow-up in 30 days ▲ ▲ = differential effects favors comprehensive parity; ○ = no differential effects; shapes do not represent effect magnitude.
See detailed data in Appendix Table D-4, available online.
a More comprehensive parity versus the reference group (no/weak parity) is indirectly compared to all parity vs. the reference group (weak/no parity). These groups are not mutually exclusive.
b Mutually exclusive groups of more comprehensive parity are compared to more limited forms of parity (reference group in each comparison: no/ weak parity).
c Uninsured population not covered by parity legislation.
MH, mental health; MHI-5, Mental Health Inventory-5; SA, substance abuse
